Hemoptysis is one of the serious complication of many pulmonary diseases. Upto now, there is no proven medical treatment in recurrence of hemoptysis. The investigators will conduct a randomized, placebo controlled trial of tranexamic acid, which can reduce the recurrence of hemoptysis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
tranexamic acid 250mg tid for 1 months vs. placebo for 1 months
Seoul National University Bundang Hospital
Seongnam-si, South Korea
Seoul National University Hospital
Seoul, South Korea
Seoul Metropolitan Government Seoul National University Boramae Medical Center
Seoul, South Korea
the proportion of recurrence of hemoptysis
Time frame: 6 month: 1months medication + 5months observation
time to recurrence
Time frame: 6 month: 1months medication + 5months observation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.